RE: Conference call Thurs.... Phase 11 starting!They continue to discover more positives about Exherin.
"The Company now believes that ADH-1 may have two modes of anti- tumor activity - targeting both the cells of the tumor vessels as well as the tumor cells themselves"
The next phase will enroll 200 patients. I think even you SS might be pleased with that number. As well they are increasing dosages without problems, another positive.
"An update on the European Phase Ib/II trial, where enrollment is already underway using a denser drug administration schedule of weekly dosing. "
Things will start happening soon with phase11 trials starting soon.
"The first Phase II study, described above, is expected to begin in the second quarter of 2005. In total, the Company expects to enroll approximately 200 or more patients with N-cadherin positive tumors in its Phase II program."
I think we might have seen the bottom of this thing and should head north of here. If positive results come from phase11 [ and why would we think they wouldn't given what's happened so far] this thing could take off like a rocket. Our patience might very well be rewarded yet.
Regards, DH